Name | Title |
Since |
Hong Kong Exchanges and Clearing Limited (Financial & Commodity Market Operators) |
Independent Non-Executive Director |
2021 |
Zai Lab Limited (Pharmaceuticals) |
Director |
2014 |
CanSino Biologics Inc. (Pharmaceuticals) |
Non-Executive Director |
2015 |
Qiming Venture Partners Ltd. |
Managing Partner |
2009 |
Pacific Advantage (International) Ltd. |
Director |
- |
Shenogen Pharma Group Ltd. |
Director |
- |
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. |
Director |
2016 |
Zhejiang Nurotron Nerve Electronic Technology Co Ltd |
Director |
2014 |
New Horizon Health Sciences Co. Ltd. |
Director |
2018 |
Hangzhou New Horizon Health Technology Co., Ltd. |
Director |
2017 |
Nurotron Biotechnology, Inc. |
Director |
- |
Qiming Development Hk Ltd. |
Partner |
2007 |